Role of allelic genes of matrix metalloproteinases and their tissue inhibitors in the risk of peptic ulcer disease development

详细信息    查看全文

• 作者：E. Kh. Shaymardanova ; A. Kh. Nurgalieva ; I. M. Khidiyatova…
• 关键词：peptic ulcer disease ; polymorphic variants of gene ; matrix metalloproteinases ; association
• 刊名：Russian Journal of Genetics
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：52
• 期：3
• 页码：320-330
• 全文大小：295 KB
• 参考文献：1.Konturek, S.J., Helicobacter pylori and Its Involvement in Gastritis and Peptic Ulcer Formation, Konturek, S.J. and Konturek, P.C., Eds., J. Physiol. Pharmacol., 2006, vol. 57, no. 3, pp. 29–50.PubMed
  2.Zelickson, M.S., Bronder, C.M., Johnson, B.L., et al., Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation, Am. Surg., 2011, vol. 77, pp. 1054–1060.PubMed
  3.Bertleff, M.J. and Lange, J.F., Perforated peptic ulcer disease: a review of history and treatment, Dig. Surg., 2010, vol. 27, pp. 161–169.CrossRef PubMed
  4.Lau, J.Y., Sung, J., Hill, C., et al., Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality, Digestion, 2011, vol. 84, pp. 102–113.
  5.http://wwwmednetru
  6.Baranovskii, A.Yu., Gastroenterologiya: spravochnik (Gastroenterology: Reference Book), Baranovskii, A.Yu., Ed., St. Petersburg: Piter, 2011.
  7.Go, M.F., Natural history and epidemiology of Helicobacter pylori infection, Aliment. Pharmacol. Ther., 2002, vol. 16, pp. 3–15.CrossRef PubMed
  8.Aljamal, A., Effects of turmeric in peptic ulcer and Helicobacter pylori, Plant Sci. Res., 2011, vol. 3, pp. 25–28.
  9.Snaith, A. and El-Omar, E.M., Helicobacter pylori: host genetics and disease outcomes, Expert Rev. Gastroenterol. Hepatol., 2008, vol. 2, no. 4, pp. 577–585.CrossRef PubMed
  10.Pasieshvili, L.M. and Morgulis, M.V., State and role of cytokines in formation and progression of diseases of the alimentary channel, Suchasna Gastroenterol., 2004, no. 3, pp. 8–11.
  11.Tsaregorodtseva, T.M., Zotina, M.M., and Serova, T.I., Interleukins in chronic diseases of digestive organs, Ter. Arkh., 2003, no. 2, pp. 7–9.
  12.Mathew, C.C., The isolation of high molecular weight eukaryotic DNA, Methods Mol. Biol., 1984, vol. 2, pp. 31–34.
  13.Santtila, S., Savinainen, K., Hurme, M., et al., Presence of the IL-1RA allele 2 (IL-1RN*2) is aßsociated with enhanced IL-1ß production in vitro, Scand. J. Immunol., 1998, vol. 47, pp. 195–198.CrossRef PubMed
  14.Hull, J., Ackerman, H., Isles, K., et al., Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus, Am. J. Hum. Genet., 2001, vol. 69, pp. 413–419.PubMed
  15.Karplus, T.M., Jeronimo, S.M., Chang, H., et al., Association between the tumor necrosis factor locus and the clinical outcome the Leishmania chagasi infection, Infect. Immun., 2002, vol. 70, no. 12, pp. 6919–6925.CrossRef PubMed PubMedCentral
  16.Hang, L.W., Hsia, T.C., Chen, W.C., et al., Interleukin10 gene–627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma, J. Clin. Lab. Anal., 2003, vol. 17, no. 5, pp. 168–173.PubMed
  17.Schlesselman, J., Case-Control Studies: Design, Conduct, Analysis, New York: Oxford Univ. Press, 1982, pp. 58–96.
  18.Abramson, J.H., WINPEPI updated: computer programs for epidemiologists, and their teaching potential, Epidemiol. Perspect. Innovations, 2011, vol. 8, pp. 1–9.CrossRef
  19.Higgins, J.P. and Thompson, S.G., Quantifying heterogeneity in a meta-analysis, Stat. Med., 2002, vol. 21, pp. 1539–1558.CrossRef PubMed
  20.Lou, X.Y., Chen, G.B., Yan, L., et al., A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence, Am. J. Hum. Genet., 2007, vol. 80, no. 6, pp. 1125–1137.CrossRef PubMed PubMedCentral
  21.Saarialho-Kere, U.K., Vaalamo, M., Puolakkainen, P., et al., Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers, Am. J. Pathol., 1996, vol. 148, pp. 519–526.PubMed
  22.Bobkova, I.N., Kozlovskaya, L.V., and Li, O.A., Matrix metalloproteinases in the pathogenesis of acute and chronic kidney disease (review of literature), Nefrol. Dializ, 2010, vol. 10, no. 2, pp. 105–111.
  23.Cheng, H.-C., Yang, H.-B., Chang, W.-L., et al., Expression of MMPs and TIMP-1 in gastric ulcers may differentiate H. pylori-infected from NSAID-related ulcers, Sci. World J., 2012, pp. 1–9.
  24.Tomita, M., Ando, T., Minami, M., et al., Potential role for matrix metalloproteinase-3 in gastric ulcer healing, Digestion, 2009, vol. 79, pp. 23–29.CrossRef PubMed
  25.Yeh, Y.-Ch., Cheng, H.-Ch., Chang, W.-L., et al., Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females, Microbiology, 2010, vol. 10, pp. 218–225.PubMed PubMedCentral
  26.Dey, S., Stalin, S., Gupta, A., et al., Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in Eastern Indian population, Mol. Carcinog., 2011, vol. 51, pp. 1–12.
  27.Kim, S-J., Park, Y.S., Paik, H.D., et al., Effect of anthocyanins on expression of matrix metalloproteinase-2 in naproxen-induced gastric ulcers, Br. J. Nutr., 2011, vol. 106, pp. 1792–1801.CrossRef PubMed
  28.Yang, T.-F., Guo, L., and Wang, Q., Meta-analysis of association between for polymorphisms in the matrix metalloproteinases gene in gastric cancer risk, Asian Pac. J. Cancer Prev., 2014, vol. 15, no. 3, pp. 1263–1267.CrossRef PubMed
  29.Matsumura, S., Oue, N., Nakayama, H., et al., A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer, J. Cancer Res. Clin. Oncol., 2005, vol. 131, pp. 19–25.CrossRef PubMed
  30.Lin, X.D., Chen, G., Li, C., et al., Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer, Chin. J. Prev. Med., 2011, vol. 45, no. 8, pp. 711–716.
  31.Zheng, J., Chu, D., Wang, D., et al., Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer, J. Surg. Oncol., 2013, vol. 107, no. 7, pp. 746–751.CrossRef PubMed
  32.Li, S., Zhou, W., Assomaning, A., et al., Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer, Carciogenesis, 2006, vol. 27, pp. 1024–1029.
  33.Haq, I., Chappel, S., Johnson, S.R., et al., Association of MMP-12 polymorphisms with severe and very severe COPD: a case control study of MMPs-1,9 and 12 in a European population, BMC Med. Genet., 2010, vol. 11, pp. 1–11.CrossRef
  34.Perez-Hernandes, N., Vargas-Alarcon, G., MartinazRodrigues, N., et al., The matrix metalloproteinase-2— 1575 gene polymorphisms is associated with the risk of developing myocardial infarction in Mexican patients, J. Atheroscler. Thromb., 2012, vol. 19, pp. 718–727.CrossRef
  35.Ramnath, N. and Creaven, P.J., Matrix metalloproteinase inhibitors, Curr. Oncol. Rep., 2004, vol. 6, no. 2, pp. 96–102.CrossRef PubMed
  36.Murphy, G. and Nagase, H., Progress in matrix metalloproteinase research, Mol. Aspects Med., 2008, vol. 29, no. 5, pp. 290–308.CrossRef PubMed PubMedCentral
  37.Sounni, N.E., Janssen, M., Foidart, J.M., and Noel, A., Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis, Matrix Biol., 2003, vol. 22, no. 1, pp. 55–61.CrossRef PubMed
  38.Brew, K., Dinakarpandian, D., and Nagase, H., Tissue inhibitors of metallo-proteinases: evolution, structure and function, Biochim. Biophys. Acta, 2000, vol. 1477, pp. 267–283.CrossRef
  39.Wieczorek, E., Reszka, E., Jablonowski, Z., et al., Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility, BJU Int., 2013, vol. 8, pp. 1207–1214.
  
• 作者单位：E. Kh. Shaymardanova (1)
  A. Kh. Nurgalieva (1)
  I. M. Khidiyatova (1)
  L. V. Gabbasova (2)
  O. A. Kuramshina (2)
  A. Ya. Kryukova (2)
  R. B. Sagitov (3)
  F. R. Munasipov (4)
  E. Kh. Khusnutdinova (1)
  
  1. Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, 450076, Russia
  2. Department of Polyclinic Therapy, Bashkir State Medical University, Ufa, 450000, Russia
  3. Emergency Hospital, Ufa, 450000, Russia
  4. Republican Clinical Oncological Dispensary, Ufa, 450000, Russia
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Human Genetics
  Animal Genetics and Genomics
  Microbial Genetics and Genomics
  Russian Library of Science
  
• 出版者：MAIK Nauka/Interperiodica distributed exclusively by Springer Science+Business Media LLC.
• ISSN：1608-3369

文摘

Peptic ulcer disease is a chronic disease of the gastrointestinal tract, mainly manifesting itself in the formation of the fairly persistent ulcer defect of the mucous membrane of the stomach and/or duodenum. Association analysis of common polymorphisms of matrix metalloproteinases genes MMP-1 (rs1799750, rs494379), MMP-2 (rs2285052), MMP-3 (rs3025058), MMP-9 (rs3918242, rs17576), and MMP-12 (rs2276109) and their tissue inhibitors TIMP-2 (rs8179090) and TIMP-3 (rs9619311) was carried out in 353 patients with a gastric ulcer or duodenal ulcer and in 325 unrelated healthy individuals from the Republic of Bashkortostan. Associations of polymorphic variants rs1799750 and rs494379 of gene MMP-1, rs3025058 of gene MMP-3, rs3918242 and rs17576 of gene MMP-9, and rs9619311 of gene TIMP-3 with the risk of peptic ulcer disease in Russians and Tatars were revealed.